Dysregulation of P2X7 receptor-inflammasome axis in SAPHO syndrome: successful treatment with anakinra

Rheumatology (Oxford). 2010 Jul;49(7):1416-8. doi: 10.1093/rheumatology/keq074. Epub 2010 Mar 18.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acquired Hyperostosis Syndrome / drug therapy*
  • Antirheumatic Agents / therapeutic use*
  • Female
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Middle Aged
  • Receptors, Purinergic P2X7 / metabolism*
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein
  • Receptors, Purinergic P2X7